MP10-09 FIFTEEN YEARS AFTER TREATMENT WITH ONE ADJUVANT CYCLE OF ETOPOSIDE, BLEOMYCIN AND CISPLATIN CHEMOTHERAPY OUTCOMES IN PATIENTS WITH HIGH RISK NONSEMINOMATOUS GERM CELL TUMORS CLINICAL STAGE I. EXTENDED FOLLOW UP OF A PROSPECTIVE SINGLE ARM CLINICAL TRIAL COHORT
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.